VYGR
Voyager Therapeutics Inc
2.50$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.9% | 91.0% | 87.1% | 87.5% | 87.7% | 70.4% | 69.4% | 70.8% | 76.2% | 80.3% | 67.0% | 63.3% | |
| 22.2% | 19.6% | 30.5% | 17.5% | 26.4% | 18.2% | 21.2% | 13.6% | 15.7% | 25.9% | 19.7% | 18.1% | |
| 85.8% | 65.7% | 85.1% | 85.1% | 81.1% | 67.8% | 66.8% | 66.9% | 72.5% | 77.9% | 64.5% | 58.8% | |
| 1.1% | 24.0% | 0.7% | 0.7% | 4.6% | 1.1% | 0.6% | 0.8% | 1.4% | 0.7% | 0.8% | 1.6% | |
| – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 40.2% | 32.7% | 27.4% | 23.1% | 22.5% | 23.7% | 22.8% | 24.3% | 23.8% | 22.3% | 20.8% | 21.9% | |
| 20.9% | 18.4% | 15.5% | 9.2% | 10.4% | 12.7% | 11.4% | 13.0% | 12.3% | 10.5% | 8.0% | 8.4% | |
| 1.1% | 0.9% | 1.3% | 1.5% | 1.6% | 1.8% | 2.1% | 2.4% | 2.7% | 3.1% | 3.4% | 3.5% | |
| 1.1% | 0.5% | 1.6% | 0.6% | 0.7% | 1.0% | 0.7% | 0.6% | 0.7% | 2.0% | 1.2% | 0.8% | |
| 59.8% | 67.3% | 72.6% | 76.9% | 77.5% | 76.3% | 77.2% | 75.7% | 76.2% | 77.7% | 79.2% | 78.1% | |
| -107.8% | -74.4% | -58.0% | -64.8% | -68.5% | -83.0% | -101.1% | -121.3% | -145.1% | -176.7% | -216.0% | -252.0% | |
| 14.9% | 12.8% | 12.2% | 13.2% | 13.6% | 14.7% | 16.5% | 18.2% | 20.4% | 23.3% | 27.1% | 30.6% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.